[Does Hepavis have value in the therapy of fatty liver caused by alcohol poisoning?].

Abstract

During the therapy of fatty liver (resp. fatty liver hepatitis) the additional application of Hepavis besides the prohibition of alcohol does not have any advantages in comparison to an additional application of a placebo. So the significant decrease of the fat content of the liver under those circumstances seems to be only the consequence of lacking alcohol consume, but not a specific effect of Hepavis. Consequently the treatment of alcoholtoxic fatty liver can be no other than to avoid alcohol, one of the most important causes of illness nowadays.

• Authors: S Odegaard, D Busch
• Journal: Zeitschrift fur Gastroenterologie (Z Gastroenterol) Vol. 27 Issue 2 Pg. 91-3 (Feb 1989) ISSN: 0044-2771 [Print] Germany
• Vernacular Title: Hat Hepavis einen Stellenwert in der Therapie der äthyltoxischen Fettleber?
• PMID: 2658394 (Publication Type: Clinical Trial, English Abstract, Journal Article)

Chemical References

• Drug Combinations
• Orotic Acid
• choline, dehydrocholic acid, magnesium orotate, orotic acid, Vitamin B12 drug combination
• Choline
• Dehydrocholic Acid
• Vitamin B 12

Topics

• Adult
• Choline (therapeutic use)
• Clinical Trials as Topic
• Dehydrocholic Acid (therapeutic use)
• Double-Blind Method
• Drug Combinations (therapeutic use)
• Fatty Liver, Alcoholic (drug therapy, pathology)
• Female
• Follow-Up Studies
• Humans
• Liver (pathology)
• Liver Function Tests
• Male
• Middle Aged
• Orotic Acid (therapeutic use)
• Random Allocation
• Vitamin B 12 (therapeutic use)